Nat Nasomyont

8PUBLICATIONS
13CO-AUTHORS
Adolescent healthMolecular medicinePharmacogenomicsClinical nutritionPhotonics, optoelectronics and optical communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 30, 2026
The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density.

Nat Nasomyont, Cuixia Tian, Lindsey Hornung

|Jan 09, 2026
Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone.

Anne Marie Sbrocchi, Kathi Kinnett, Maria-Elena Lautatzis

|Dec 23, 2025
Acute Adverse Events Following Intravenous Bisphosphonate Infusion Are Uncommon in Patients With Duchenne Muscular Dystrophy Previously Treated With Oral Bisphosphonates.

Nat Nasomyont, Pitchamol Vilaisaktipakorn, Halley Wasserman

|Feb 20, 2025
A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing Landscape.

Leanne M Ward, David R Weber, Sze Choong Wong

|Nov 01, 2023
Successful Treatment of Hypoglycemia With Alpelisib in Pediatric Patients With PIK3CA-Related Overgrowth Spectrum.

Nat Nasomyont, Meilan M Rutter, Philippe F Backeljauw

|Sep 10, 2021
The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis.

Nat Nasomyont, Cuixia Tian, Lindsey Hornung

Pageof 2

Frequent Collaborators

3 joint publications

Meilan M Rutter

2 joint publications

Halley Wasserman

1 joint publications

Philippe F Backeljauw

1 joint publications

Leanne M Ward